2009

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Marks DI et al Blood. 2009 Dec 10;114(25):5136-45.

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B cell precursor acute lymphoblastic leukemia. Russell LJ et al Blood. 2009 Sep 24;114(13):2688-98.

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Balgobind BV et al Blood. 2009 Sep 17;114(12):2489-96.

Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21. An Q et al Haematologica. 2009 Aug;94(8):1164-9.

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Fielding AK et al. Blood. 2009 May 7;113(19):4489-96.

Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials. Wheatley K et al. on behalf of the United Kingdom National Cancer Research Institute Haematological Oncology Clinical Studies Group and Acute Myeloid Leukaemia Subgroup. Br J Haematol. 2009 Mar 20 145(5):598-605.

Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia. Paulsson K et al. Br J Haematol. 2009 Mar;144(6):838-47.

A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Russell LJ et al. Leukemia. 2009 Mar;23 (3):614-7

Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Harrison CJ. Br J Haematol. 2009 Jan;144(2):147-56

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Graux C et al. on behalf of the Groupe Francophone de Cytogénétique Hématologique and the Belgian Cytogenetic Group for Hematology and Oncology. Leukemia. 2009 Jan;23(1):125-33

A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Sulong S et al. Blood. 2009 Jan;113(1):100-7